Immatics Profitability Analysis

IMTX -  USA Stock  

USD 13.06  0.36  2.68%

For Immatics profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Immatics to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Immatics NV utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Immatics's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Immatics NV over time as well as its relative position and ranking within its peers. Please see Risk vs Return Analysis.

Immatics Current Profitability Trends 

 
Refresh
Price to Sales Ratio is likely to rise to 13.95 in 2021, whereas Return on Sales is likely to drop (7.56)  in 2021. Net Income to Non Controlling Interests is likely to rise to about 627.8 K in 2021, whereas Consolidated Income is likely to drop (235.7 M) in 2021.

Immatics Revenues

26.77 MillionShare
The market value of Immatics NV is measured differently than its book value, which is the value of Immatics that is recorded on the company's balance sheet. Investors also form their own opinion of Immatics' value that differs from its market value or its book value, called intrinsic value, which is Immatics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immatics' market value can be influenced by many factors that don't directly affect Immatics NV underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immatics' value and its price as these two are different measures arrived at by different means. Investors typically determine Immatics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immatics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Immatics NV Revenue vs. Current Ratio Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Immatics's current stock value. Our valuation model uses many indicators to compare Immatics value to that of its competitors to determine the firm's financial worth.
Immatics NV is rated below average in current ratio category among related companies. It is rated second overall in revenue category among related companies totaling about  9,669,725  of Revenue per Current Ratio. . Immatics Current Ratio is fairly stable at the moment as compared to the past year. Immatics reported Current Ratio of 3.94 in 2020

Immatics Revenue vs. Current Ratio

Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Immatics 
Current Ratio 
 = 
Current Asset 
Current Liabilities 
3.27 X
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Immatics 
Revenue 
 = 
Money Received 
Discounts and Returns 
31.62 M
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

Immatics Revenue vs Competition

Immatics NV is rated second overall in revenue category among related companies. Market size based on revenue of Biotechnology industry is currently estimated at about 314.26 Million. Immatics retains roughly 31.62 Million in revenue claiming about 10% of stocks in Biotechnology industry.

Immatics Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Immatics, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Immatics will eventually generate negative long term returns. The profitability progress is the general direction of Immatics' change in net profit over the period of time. It can combine multiple indicators of Immatics, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for 2021
Consolidated Income-229.6 M-235.7 M
Net Income-229.1 M-235.1 M
Net Income Common Stock-229.1 M-235.1 M
Net Income to Non Controlling Interests557 K627.8 K
Operating Income-69.7 M-75.2 M
Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor based immunotherapies for the treatment of cancer in the United States. The company has a strategic collaboration agreement with GlaxoSmithKline plc to develop novel adoptive cell therapies targeting multiple cancer indications MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies Celgene Switzerland LLC to develop novel adoptive cell therapies targeting multiple cancers Genmab AS to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications Amgen Inc. and MorphoSys to develop novel antibody-based therapies against various cancer antigens that are recognized by T cells. Immatics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 285 people.

Immatics Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Immatics. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Immatics position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Immatics' important profitability drivers and their relationship over time.

Immatics Profitability Trends

Immatics profitability trend refers to the progression of profit or loss within a business. An upward trend means that Immatics' profit has generally increased over time, and a downward profitability trend means profits are declining. Recognizing problems early in profitability trends allows investors to address revenue and cost issues in advance. Investors and analysts usually monitor three types of profitability trends: gross, operating, and net. Gross profit is the difference between revenue and costs of goods sold. Operating profit is Immatics' gross profit minus its overhead. After you account for other unusual revenue, expenses, and costs, you get net profit. Gross profit trends are often a good indicator of future profitability. If you have high gross profit margins, you have a better chance to cover overhead and make money.

Immatics Profitability Drivers Correlations

One of the toughest challenges investors face today is learning how to quickly synthesize and read into endless financial statements and information provided by the company, SEC reporting, and various external parties. Understanding the correlation between Immatics different financial indicators related to revenue and profit generation helps investors identify and prioritize their investing strategies towards Immatics in a much-optimized way. Analyzing correlations between profit drivers that are directly associated with dollar figures is the most effective way to break down Immatics' future profitability.

Use Immatics in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Immatics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immatics will appreciate offsetting losses from the drop in the long position's value.

Immatics Pair Trading

Immatics NV Pair Trading Analysis

Correlation analysis and pair trading evaluation for Immatics and Brickell Biotech. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  

Use Investing Themes to Complement your Immatics position

In addition to having Immatics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run World Allocation Thematic Idea Now

World Allocation
World Allocation Theme
Funds or Etfs investing in stocks, bonds, and cash of domestic markets as well as in markets of Canada, Japan, and Europe. World Allocation theme has 40 constituents.
View All  Next Launch World Allocation
Please see Risk vs Return Analysis. Note that the Immatics NV information on this page should be used as a complementary analysis to other Immatics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Complementary Tools for Immatics Stock analysis

When running Immatics NV price analysis, check to measure Immatics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics is operating at the current time. Most of Immatics' value examination focuses on studying past and present price action to predict the probability of Immatics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immatics' price. Additionally, you may evaluate how the addition of Immatics to your portfolios can decrease your overall portfolio volatility.
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Fund Screener
Find activelly-traded funds from around the world traded on over 30 global exchanges
Go
To fully project Immatics' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Immatics NV at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Immatics' income statement, its balance sheet, and the statement of cash flows.
Potential Immatics investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Immatics investors may work on each financial statement separately, they are all related. The changes in Immatics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Immatics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.